Education
About Us
Working with TipRanks
Follow Us
D.N.A Biomedical Solutions Ltd (IL:DNA)
:DNA
Total Valuation
Dna Group has a market cap or net worth of 118.73M. The enterprise value is 19.60M.
Market Cap118.73M
Enterprise Value19.60M
Share Statistics
Dna Group has 123,164,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding123,164,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Dna Group’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 18.87%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.21
Return on Invested Capital (ROIC)18.87%
Return on Capital Employed (ROCE)0.20
Revenue Per Employee23.54K
Profits Per Employee1.70M
Employee Count13
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Dna Group is 0.00. Dna Group’s PEG ratio is 0.02.
PE Ratio0.00
PS Ratio0.00
PB Ratio1.07
Price to Fair Value0.00
Price to FCF-241.05
Price to Operating Cash Flow-241.05
PEG Ratio0.02
Income Statement
In the last 12 months, Dna Group had revenue of 306.00K and earned 22.10M in profits. Earnings per share was 0.00.
Revenue306.00K
Gross Profit306.00K
Operating Income20.61M
Pretax Income23.40M
Net Income22.10M
EBITDA-1.51M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 284.00K and capital expenditures 0.00, giving a free cash flow of 284.00K billion.
Operating Cash Flow284.00K
Free Cash Flow284.00K
Free Cash Flow per Share<0.01
Dividends & Yields
Dna Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.14
52-Week Price Change21.00%
50-Day Moving Average100.12
200-Day Moving Average93.43
Relative Strength Index (RSI)38.86
Average Volume (3m)402.38K
Important Dates
Dna Group upcoming earnings date is Aug 30, 2021, TBA Not Confirmed.
Last Earnings DateInvalid Date
Next Earnings DateAug 30, 2021
Ex-Dividend Date―
Financial Position
Dna Group as a current ratio of 60.77, with Debt / Equity ratio of 0.00%
Current Ratio60.77
Quick Ratio60.77
Debt to Market Cap0.00
Net Debt to EBITDA45.24
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Dna Group has paid 1.31M in taxes.
Income Tax1.31M
Effective Tax Rate0.06
Enterprise Valuation
Dna Group EV to EBITDA ratio is 45.24, with an EV/FCF ratio of -42.43.
EV to Sales-223.24
EV to EBITDA45.24
EV to Free Cash Flow-42.43
EV to Operating Cash Flow-42.43
Balance Sheet
Dna Group has 67.33M in cash and marketable securities with 0.00 in debt, giving a net cash position of -67.33M billion.
Cash & Marketable Securities67.33M
Total Debt0.00
Net Cash-67.33M
Net Cash Per Share-0.55
Tangible Book Value Per Share0.00
Margins
Gross margin is 100.00%, with operating margin of 6736.60%, and net profit margin of 7220.92%.
Gross Margin100.00%
Operating Margin6736.60%
Pretax Margin7648.04%
Net Profit Margin7220.92%
EBITDA Margin-493.46%
EBIT Margin-493.46%
Analyst Forecast
The average price target for Dna Group is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―